SARAH WHINERY: Open Payments
NPI 1255828844 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,729 in 21 payments from 9 companies in 2025. Trend: 2023 $823 · 2024 $2,082 · 2025 $1,729
Food & beverage: $1,629Education: $100
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $486 |
| Regeneron Healthcare Solutions, Inc. | 2 | $291 |
| GENZYME CORPORATION | 3 | $279 |
| LEO Pharma Inc. | 2 | $223 |
| Lilly USA, LLC | 3 | $216 |
| Janssen Biotech, Inc. | 1 | $100 |
| UCB, Inc. | 2 | $67 |
| ABBVIE INC. | 2 | $39 |
| Incyte Corporation | 1 | $28 |
Products named: DUPIXENT, OTEZLA, EBGLYSS, ADBRY, WAYRILZ, ANZUPGO, TREMFYA, Bimzelx.
Industry payments across TX — which companies pay providers there.
